LYSOGENE

LYSOGENE

LYSOGENE

Lysogene is a global leader in the basic research and clinical development of gene therapy for neurodegenerative disorders.
Founded
2009
Raised
$22M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$22,000,000
Venture capital (Series A) - 2014
Team Size
2
Employees
Location
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when LYSOGENE makes some noise.